retatrutide type 1 diabetes Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA 🩺 Retatrutide in type 2

A Prospective, Randomized Double-Blind, Placebo-Controlled Study of Safety and Efficacy of a High-Concentration Full-Spectrum Extract of Ashwagandha Root in Reducing Stress and Anxiety in Adults

GLP-1RAs may also have an impact on obesity and chronic kidney disease, conditions for which cardiovascular risk-reducing options are limited

And this one [berobenatide] is driving one of those two, whereas normally when you have a GLP-1 molecule, it drives both at the same time, he said

By bringing physicians, dietitians, behavioral health specialists, and exercise professionals together in one coordinated setting, the program helps patients move beyond prescriptions alone and develop tools they can use every day